Literature DB >> 20162651

Structure-based design of highly crowded ribostamycin/kanamycin hybrids as a new family of antibiotics.

Julia Revuelta1, Tatiana Vacas, Francisco Corzana, Carlos Gonzalez, Agatha Bastida, Juan Luis Asensio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20162651     DOI： 10.1002/chem.200903003

Source DB:  PubMed          Journal:  Chemistry        ISSN： 0947-6539            Impact factor:   5.236


× No keyword cloud information.
  4 in total

1.  Selectively guanidinylated aminoglycosides as antibiotics.

Authors:  Richard J Fair; Mary E Hensler; Wdee Thienphrapa; Quang N Dam; Victor Nizet; Yitzhak Tor
Journal:  ChemMedChem       Date:  2012-05-25       Impact factor: 3.466

2.  Apralogs: Apramycin 5-O-Glycosides and Ethers with Improved Antibacterial Activity and Ribosomal Selectivity and Reduced Susceptibility to the Aminoacyltranserferase (3)-IV Resistance Determinant.

Authors:  Jonathan C K Quirke; Parasuraman Rajasekaran; Vikram A Sarpe; Amr Sonousi; Ivan Osinnii; Marina Gysin; Klara Haldimann; Qiao-Jun Fang; Dimitri Shcherbakov; Sven N Hobbie; Su-Hua Sha; Jochen Schacht; Andrea Vasella; Erik C Böttger; David Crich
Journal:  J Am Chem Soc       Date:  2019-12-17       Impact factor: 15.419

Review 3.  Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors.

Authors:  Sandra G Zárate; M Luisa De la Cruz Claure; Raúl Benito-Arenas; Julia Revuelta; Andrés G Santana; Agatha Bastida
Journal:  Molecules       Date:  2018-01-30       Impact factor: 4.411

4.  Modification at the 2'-Position of the 4,5-Series of 2-Deoxystreptamine Aminoglycoside Antibiotics To Resist Aminoglycoside Modifying Enzymes and Increase Ribosomal Target Selectivity.

Authors:  Girish C Sati; Vikram A Sarpe; Takayuki Furukawa; Sujit Mondal; Matilde Mantovani; Sven N Hobbie; Andrea Vasella; Erik C Böttger; David Crich
Journal:  ACS Infect Dis       Date:  2019-09-13       Impact factor: 5.084
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.